tiprankstipranks
Advertisement
Advertisement
Niagen Bioscience price target lowered to $13 from $14 at Canaccord
PremiumThe FlyNiagen Bioscience price target lowered to $13 from $14 at Canaccord
2M ago
Niagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating
Premium
Ratings
Niagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating
2M ago
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift
Premium
Company Announcements
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift
2M ago
Niagen Bioscience divests hromaDex Reference Standards business to LGC
PremiumThe FlyNiagen Bioscience divests hromaDex Reference Standards business to LGC
2M ago
Niagen Bioscience Divests Non-Core Analytical Standards Business
Premium
Company Announcements
Niagen Bioscience Divests Non-Core Analytical Standards Business
2M ago
Niagen Bioscience secures new patent for nicotinamide riboside
Premium
The Fly
Niagen Bioscience secures new patent for nicotinamide riboside
2M ago
Niagen Bioscience management to meet with Roth Capital
PremiumThe FlyNiagen Bioscience management to meet with Roth Capital
5M ago
Niagen Bioscience announces results of Niagen supplementation in long COVID
Premium
The Fly
Niagen Bioscience announces results of Niagen supplementation in long COVID
5M ago
Niagen Bioscience announces $10M share repurchase program
Premium
The Fly
Niagen Bioscience announces $10M share repurchase program
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100